The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Sildenafil-associated nonarteritic anterior ischemic optic neuropathy
Abstract
Purpose To describe the clinical features of five patients who developed nonarteritic anterior ischemic optic neuropathy (NAION) after ingestion of sildenafil citrate (Viagra; Pfizer Pharmaceuticals, New York, NY). Design Retrospective observational case series. Participants Five patients with NAION who reported the use of sildenafil citrate before the onset of ocular symptoms. Main outcome measures The symptoms presented, history, ophthalmic examination, and visual field examination of each patient. Results Nonarteritic anterior ischemic optic neuropathy developed in one eye within minutes to hours after ingestion of sildenafil. Four of the five patients had no vascular risk factors for ischemic optic neuropathy. The patients all developed unilateral blurry vision, altitudinal visual field defects, and optic disc edema. Each of the patients was noted to have a small cup-to-disc ratio in the unaffected optic nerve. Conclusions Sildenafil citrate may be associated with NAION. A small cup-to-disc ratio may be a risk factor for development of NAION in association with the use of sildenafil.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, certain medications, such as phosphodiesterase-5 inhibitors20,21 and amiodarone,22 have also been linked to the development of NAION.”
From The Effect of Semaglutide and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic Neuropathy (2025) · cites this paper as [20]
Citations
Cites
Arky, R. A. (1994) · Cited by 2,632
Incidence of Nonarteritic Anteripr Ischemic Optic Neuropathy
HATTENHAUER, M. G., LEAVITT, J. A., HODGE, D. O., GRILL, R., & GRAY, D. T. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70999-7 · Cited by 437
Neufeld, A. H., Sawada, A., & Becker, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9944 · Cited by 374
Johnson, L. N., & Arnold, A. C. (1994) · Journal of Neuro-Ophthalmology · doi:10.1097/00041327-199403000-00011 · Cited by 359
Anterior Ischemic Optic Neuropathy
Beck, R. W., Servais, G. E., & Hayreh, S. S. (1987) · Ophthalmology · doi:10.1016/s0161-6420(87)33263-4 · Cited by 341
(1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140566007 · Cited by 287
Optic Disk Risk Factors for Nonarteritic Anterior Ischemic Optic Neuropathy
Burde, R. M. (1993) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)73478-6 · Cited by 202
Cup-Disc Ratio and Ischemic Optic Neuropathy
Doro, S., & Lessell, S. (1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050080055019 · Cited by 148
Anterior Ischemic Optic Neuropathy Associated With Viagra
Cunningham, A. V., & Smith, K. H. (2001) · Journal of Neuro-Ophthalmology · doi:10.1097/00041327-200103000-00006 · Cited by 103
Self-citationSildenafil (Viagra) Associated Anterior Ischemic Optic Neuropathy
Egan, R., & Pomeranz, H. D. (2000) · Archives of Ophthalmology · doi:10.1001/archopht.118.2.291 · Cited by 93
Self-citation
Cited by
Pulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 664
Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond
Ghofrani, H. A., Osterloh, I. H., & Grimminger, F. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2030 · Cited by 629
Miller, N. R., & Arnold, A. C. (2015) · Eye · doi:10.1038/eye.2014.144 · Cited by 245
Li, J., Tripathi, R. C., & Tripathi, B. J. (2008) · Drug Safety · doi:10.2165/00002018-200831020-00003 · Cited by 226
Tsertsvadze, A., Fink, H. A., Yazdi, F., MacDonald, R., Bella, A. J., Ansari, M. T., Garritty, C., Soares-Weiser, K., Daniel, R., Sampson, M., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-9-200911030-00150 · Cited by 193
“Evidence on the incidence of NAION associated with use of PDE-5 inhibitors was limited to 10 case reports (165–174), 2 case series (175, 176), and 1 retrospective cohort study (177).”
Background
Metadata
- Authors
- Pomeranz, H. D., Smith, K. H., Hart, W. M., & Egan, R. A.
- Affiliations
- University of Minnesota (US)
- Baylor Scott & White Medical Center - Temple (US)
- Washington University in St. Louis (US)
- Corresponding author
- Pomeranz, Howard D
- ORCID
- Egan, Robert A
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 109
- Issue
- 3
- Pages
- 584-587
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2075065959
- Cited by
- 173
- References
- 15
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 3 · 2018: 3 · 2017: 5 · 2016: 9 · 2015: 5 · 2014: 7 · 2013: 4 · 2012: 5
- FWCI
- 11.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Ophthalmology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Drug-Induced Ocular Toxicity
- Health Sciences › Medicine › Clinical Neurology › Cerebral Venous Sinus Thrombosis
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Keywords
- nonarteritic anterior ischemic optic neuropathy, sildenafil citrate, drug-induced optic neuropathy, cup-to-disc ratio, optic disc edema, bilateral vision loss, adverse drug reactions
- MeSH terms
- Sildenafil Citrate, Adult, Aged, Humans, Erectile Dysfunction, Male, Middle Aged, Phosphodiesterase Inhibitors, Piperazines, Purines, Risk Factors, Sulfones, Giant Cell Arteritis, 3',5'-Cyclic-GMP Phosphodiesterases, Optic Neuropathy, Ischemic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sildenafil-associated nonarteritic anterior ischemic optic neuropathy. https://app.cochat.ai/papers/10.1016/s0161-6420(01)00976-9
- The paper
- Pomeranz, H. D., Smith, K. H., Hart, W. M., & Egan, R. A. (2002). Sildenafil-associated nonarteritic anterior ischemic optic neuropathy. Ophthalmology. https://doi.org/10.1016/s0161-6420(01)00976-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.